Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10.06.2022 - SAN DIEGO, June 10, 2022 (GLOBE NEWSWIRE) - Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2022, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an ...

Related Keywords

,Crinetics Pharmaceuticals Inc ,Compensation Committee Of Crinetic Board Directors ,Nasdaq ,Compensation Committee ,Crinetic Board ,Crinetics Pharmaceuticals ,Inducement Incentive Award Plan ,Nasdaq Listing Rule ,